ArticleCardiovascular diabetology2018

The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors.

Vladimer Darsalia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.